GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

A team of microbiologists, chemists and pharmaceutical specialists at Shandong University, Guangzhou Medical University, ...

The pursuit of health, vitality, and longevity is no longer just about avoiding disease—it’s about thriving at every stage of ...

While first-generation glucagon-like peptide-1 receptor agonists have clearly taken the obesity market by storm, generating billions of dollars for Novo Nordisk A/S and Eli Lilly and Co., several ...

Studies suggest collagen supplementation may help improve conditions such as osteoarthritis, osteoporosis, sarcopenia, ...

The findings of this study provide initial prospective evidence that low-dose semaglutide can reduce craving and some drinking outcomes, justifying larger clinical trials to evaluate glucagon-like ...

Being the first and only certified peptide clinic in northern Louisiana, physicians must have extensive training. Peptides are little mini proteins. They’re naturally found in the body and, as we age, ...

More information about the 2025 AAAAI / WAO Joint Congress can be accessed here.

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...